Mannose‐binding lectin genotype and serum levels in patients with chronic and allergic pulmonary aspergillosis
- 9 January 2012
- journal article
- research article
- Published by Wiley in International Journal of Immunogenetics
- Vol. 39 (3), 224-232
- https://doi.org/10.1111/j.1744-313x.2011.01078.x
Abstract
Several studies suggest mannose‐binding lectin (MBL) deficiency is associated with various manifestations of aspergillosis. MBL serum levels and function are genetically determined, but levels rise during inflammation. We address the relative frequency of deficient genotypes, the relationship between serum level and genotype and both age and disease manifestations in patients with chronic pulmonary (CPA) and allergic bronchopulmonary aspergillosis (ABPA) and severe asthma with fungal sensitization (SAFS). DNA was extracted from blood samples, and MBL2 genotyping was performed using the INNO‐LiPA MBL2 kit. Serum MBL concentrations were determined using ELISA. One hundred and eight patients were evaluated, 70 (65%) with CPA, 38 (35%) with allergic disease (ABPA, SAFS or undefined) and 13 (12%) had both CPA and ABPA. The mean MBL serum level was 1849 μg L−1 and did not differ between groups. Forty subjects (37%) had exon 1 genotypes producing nonfunctional MBL (A/B, A/C, A/D and O/O), a frequency not different from published normal controls. A/A subjects with CPA had higher levels (2981 μg L−1) compared with allergic A/A subjects (2202 μg L−1) (pc0.012). No single haplotype, genotype or allele was significantly related to any aspergillosis phenotype. Worse breathlessness was associated with higher MBL levels among A/A subjects (P = 0.009) and conversely nonfunctional genotypes. Mean MBL values were higher in those with an Medical Research Council (MRC) breathlessness score of 5 compared with those with and MRC score of 1 (P = 0.023). A/A allergic subjects (n = 27) in this study were ∼11 years younger than allergic A/O subjects (n = 11, P = 0.02). Subjects with worse respiratory status or more severe CPA had higher MBL serum levels (P = 0.023; P = 0.034). Bronchiectasis was not associated with MBL levels in CPA or allergic aspergillosis. MBL genotype and serum level modulate progression of aspergillosis.Keywords
This publication has 57 references indexed in Scilit:
- Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosisBulletin of the World Health Organization, 2011
- Underlying conditions in chronic pulmonary aspergillosis including simple aspergillomaEuropean Respiratory Journal, 2010
- Resistance of MBL gene-knockout mice to experimental systemic aspergillosisImmunology Letters, 2010
- Association of Mannose‐Binding Lectin Deficiency with Acute Invasive Aspergillosis in Immunocompromised PatientsClinical Infectious Diseases, 2009
- Association of IL4R gene polymorphisms with asthma in Chinese populationsHuman Mutation, 2007
- Association between mannan-binding lectin and impaired lung function in cystic fibrosis may be age-dependentClinical and Experimental Immunology, 2006
- Plasma mannan-binding lectin levels and activity are increased in allergic patientsJournal of Allergy and Clinical Immunology, 2005
- A Comprehensive Analysis of Interleukin-4 Receptor Polymorphisms and Their Association with Atopy and IgE Regulation in ChildhoodInternational Archives of Allergy and Immunology, 2004
- Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax, 1999
- Human Serum Mannose Binding Protein (MBP): Development of an Enzyme-Linked Immunosorbent Assay (ELISA) and Determination of Levels in Serum from 1085 Normal Japanese and in Some Body FluidsBiochemical Medicine and Metabolic Biology, 1993